129 related articles for article (PubMed ID: 9649231)
1. Germ cell tumors: staging, prognosis, and outcome.
Prow DM
Semin Urol Oncol; 1998 May; 16(2):82-93. PubMed ID: 9649231
[TBL] [Abstract][Full Text] [Related]
2. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only.
Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R
J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870
[TBL] [Abstract][Full Text] [Related]
3. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
Eggener SE; Carver BS; Sharp DS; Motzer RJ; Bosl GJ; Sheinfeld J
J Urol; 2007 Mar; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
[TBL] [Abstract][Full Text] [Related]
4. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
[TBL] [Abstract][Full Text] [Related]
5. Histologic type, staging, and distribution of germ cell tumors in Korean adults.
Park DS; Chung MK; Chung JI; Ahn HJ; Lee ES; Choi HY; Yoon DK; Cheon J; Hong SJ; Lee YG; Yoon SM; Kim WJ; Kim HJ; Ryu SB; Ro JY
Urol Oncol; 2008; 26(6):590-4. PubMed ID: 18367106
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic retroperitoneal lymphadenectomy for stage I non-seminomatous testicular tumors.
Custureri F; Urciuoli P; Iavarone C; D'Orazi V; Gabatel R; Ghinassi S; Patrizi G; Palazzini G; Di Matteo FM; Peparini N
Hepatogastroenterology; 2005; 52(66):1677-80. PubMed ID: 16334755
[TBL] [Abstract][Full Text] [Related]
7. Multicenter study of human immunodeficiency virus-related germ cell tumors.
Powles T; Bower M; Daugaard G; Shamash J; De Ruiter A; Johnson M; Fisher M; Anderson J; Mandalia S; Stebbing J; Nelson M; Gazzard B; Oliver T
J Clin Oncol; 2003 May; 21(10):1922-7. PubMed ID: 12743144
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of clinical and histopathologic diagnosis for early stages of advanced nonseminomatous germ cell testicular tumors].
Sosnowski M; Płuzańska A; Chmielowski M; Dowgier-Witczak I; Jeromir L
Pol Merkur Lekarski; 1997 Apr; 2(10):273-6. PubMed ID: 9377665
[TBL] [Abstract][Full Text] [Related]
9. Improved long term survival of patients with metastatic nonseminomatous testicular germ cell carcinoma in relation to prognostic classification systems during the cisplatin era.
Sonneveld DJ; Hoekstra HJ; van der Graaf WT; Sluiter WJ; Mulder NH; Willemse PH; Koops HS; Sleijfer DT
Cancer; 2001 Apr; 91(7):1304-15. PubMed ID: 11283931
[TBL] [Abstract][Full Text] [Related]
10. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001.
Holzbeierlein JM; Sogani PC; Sheinfeld J
J Urol; 2003 Jun; 169(6):2122-5. PubMed ID: 12771732
[TBL] [Abstract][Full Text] [Related]
11. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin, etoposide and either bleomycin or ifosfamide in the treatment of disseminated germ cell tumors: final analysis of an intergroup trial.
Hinton S; Catalano PJ; Einhorn LH; Nichols CR; David Crawford E; Vogelzang N; Trump D; Loehrer PJ
Cancer; 2003 Apr; 97(8):1869-75. PubMed ID: 12673712
[TBL] [Abstract][Full Text] [Related]
13. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumours of the testis.
Gori S; Porrozzi S; Roila F; Gatta G; De Giorgi U; Marangolo M
Crit Rev Oncol Hematol; 2005 Feb; 53(2):141-64. PubMed ID: 15661565
[TBL] [Abstract][Full Text] [Related]
15. Results of bilateral nerve sparing laparoscopic retroperitoneal lymph node dissection for testicular cancer.
Steiner H; Zangerl F; Stöhr B; Granig T; Ho H; Bartsch G; Peschel R
J Urol; 2008 Oct; 180(4):1348-52; discussion 1352-3. PubMed ID: 18707723
[TBL] [Abstract][Full Text] [Related]
16. Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center.
Che M; Tamboli P; Ro JY; Park DS; Ro JS; Amato RJ; Ayala AG
Cancer; 2002 Sep; 95(6):1228-33. PubMed ID: 12216089
[TBL] [Abstract][Full Text] [Related]
17. Stage I nonseminomatous germ cell tumors: the case for management by risk stratification.
Al Ghamdi AM; Jewett MA
Can J Urol; 2005 Feb; 12 Suppl 1():62-5; discussion 103-4. PubMed ID: 15780169
[TBL] [Abstract][Full Text] [Related]
18. Impact of the number of positive lymph nodes on disease-free survival in patients with pathological stage B1 nonseminomatous germ cell tumor.
Beck SD; Foster RS; Bihrle R; Cheng L; Ulbright TM; Donohue JP
J Urol; 2005 Jul; 174(1):143-5. PubMed ID: 15947600
[TBL] [Abstract][Full Text] [Related]
19. What does the pathology report really mean?
Ro JY; Amato RJ; Ayala AG
Semin Urol Oncol; 1996 Feb; 14(1):2-7. PubMed ID: 9132264
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]